When evaluating patient-education strategies among individuals with IBD, investigators found vaccine uptake was unaffected by educational videos and text-based interventions, identifying prior vaccine receipt as the strongest predictor of future vaccination.
Empagliflozin s efficacy in a range of patients with chronic kidney disease in EMPA-Kidney filled evidence gaps and confirmed SGLT2 inhibitors as a key treatment regardless of diabetes status.
will keep a beady ion. there is experience in other countries, the usa, canada, france and so forth. i m sure they will be keeping a watching brief as more data becomes available in the roll out of the vaccines to younger ages. the trouble is vaccines to younger ages. the trouble is that vaccines to younger ages. the trouble is that even if it is rolled out to younger ages, how many will take it up? we are seeing that amongst people in the 20 30 age group but not necessarily a great take up on the vaccine. i group but not necessarily a great take-up on the vaccine.- take-up on the vaccine. i think that s a real take-up on the vaccine. i think that s a real issue, take-up on the vaccine. i think that s a real issue, and - take-up on the vaccine. i think| that s a real issue, and clearly, people are thinking how you can improve uptake and it is something thatis improve uptake and it is something that is very important because as i say, the protection comes from as many people as